Search | VHL Search Portal

1.

A phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receiving combination cediranib and olaparib.

Liu, Joyce F; Xiong, Niya; Wenham, Robert M; Wahner-Hendrickson, Andrea; Armstrong, Deborah K; Chan, Nancy; O'Malley, David M; Lee, Jung-Min; Penson, Richard T; Cristea, Mihaela C; Abbruzzese, James L; Matsuo, Koji; Olawaiye, Alexander B; Barry, William T; Cheng, Su-Chun; Polak, Madeline; Swisher, Elizabeth M; Shapiro, Geoffrey I; Kohn, Elise C; Ivy, S Percy; Matulonis, Ursula A.

Gynecol Oncol ; 187: 105-112, 2024 May 16.

Article in English | MEDLINE | ID: mdl-38759516

2.

Uterine MEIS1::NCOA2 Fusion Sarcoma With Lung Metastasis: A Case Report and Review of the Literature.

Xing, Deyin; Meyer, Christian F; Gross, John M; Argani, Pedram; Hung, Chien-Fu; Wu, T-C; Vang, Russell; Armstrong, Deborah K; Gaillard, Stéphanie L.

Int J Gynecol Pathol ; 43(1): 47-55, 2024 Jan 01.

Article in English | MEDLINE | ID: mdl-37043646

3.

Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer.

Herzog, Thomas J; Pignata, Sandro; Ghamande, Sharad A; Rubio, Maria-Jesús; Fujiwara, Keiichi; Vulsteke, Christof; Armstrong, Deborah K; Sehouli, Jalid; Coleman, Robert L; Gabra, Hani; Scambia, Giovanni; Monk, Bradley J; Arranz, José A; Ushijima, Kimio; Hanna, Rabbie; Zamagni, Claudio; Wenham, Robert M; González-Martín, Antionio; Slomovitz, Brian; Jia, Yan; Ramsay, Lisa; Tewari, Krishnansu S; Weil, Susan C; Vergote, Ignace B.

Gynecol Oncol ; 170: 300-308, 2023 03.

Article in English | MEDLINE | ID: mdl-36758420

4.

Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer.

Coleman, Robert L; Spirtos, Nick M; Enserro, Danielle; Herzog, Thomas J; Sabbatini, Paul; Armstrong, Deborah K; Kim, Jae-Weon; Park, Sang-Yoon; Kim, Byoung-Gie; Nam, Joo-Hyun; Fujiwara, Keiichi; Walker, Joan L; Casey, Ann C; Alvarez Secord, Angeles; Rubin, Steve; Chan, John K; DiSilvestro, Paul; Davidson, Susan A; Cohn, David E; Tewari, Krishnansu S; Basen-Engquist, Karen; Huang, Helen Q; Brady, Mark F; Mannel, Robert S.

N Engl J Med ; 381(20): 1929-1939, 2019 11 14.

Article in English | MEDLINE | ID: mdl-31722153

5.

What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (≥10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer.

Pitiyarachchi, Omali; Friedlander, Michael; Java, James J; Chan, John K; Armstrong, Deborah K; Markman, Maurie; Herzog, Thomas J; Monk, Bradley J; Backes, Floor; Secord, Angeles Alvarez; Bonebrake, Albert; Rose, Peter G; Tewari, Krishnansu S; Lentz, Samuel S; Geller, Melissa A; Copeland, Larry J; Mannel, Robert S.

Gynecol Oncol ; 166(3): 410-416, 2022 09.

Article in English | MEDLINE | ID: mdl-35835612

6.

NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022.

Armstrong, Deborah K; Alvarez, Ronald D; Backes, Floor J; Bakkum-Gamez, Jamie N; Barroilhet, Lisa; Behbakht, Kian; Berchuck, Andrew; Chen, Lee-May; Chitiyo, Viola C; Cristea, Mihaela; DeRosa, Maria; Eisenhauer, Eric L; Gershenson, David M; Gray, Heidi J; Grisham, Rachel; Hakam, Ardeshir; Jain, Angela; Karam, Amer; Konecny, Gottfried E; Leath, Charles A; Leiserowitz, Gary; Liu, Joyce; Martin, Lainie; Matei, Daniela; McHale, Michael; McLean, Karen; Miller, David S; Percac-Lima, Sanja; Remmenga, Steven W; Schorge, John; Stewart, Daphne; Thaker, Premal H; Vargas, Roberto; Hendrickson, Andrea Wahner; Werner, Theresa L; Zsiros, Emese; Dwyer, Mary A; Hang, Lisa.

J Natl Compr Canc Netw ; 20(9): 972-980, 2022 09.

Article in English | MEDLINE | ID: mdl-36075393

7.

Post hoc analyses of GOG 9923: Does BRCA status affect toxicities?: An NRG oncology study.

Gillen, Jessica; Miller, Austin; Bell-McGuinn, Katherine M; Schilder, Russell J; Walker, Joan L; Mathews, Cara A; Duska, Linda R; Guntupalli, Saketh R; O'Cearbhaill, Roisin; Hays, John; Hagemann, Andrea R; Gray, Heidi J; Gordon, Sarah W; Armstrong, Deborah K; Chen, Alice; Fracasso, Paula M; Aghajanian, Carol; Moore, Kathleen N.

Gynecol Oncol ; 161(2): 512-515, 2021 05.

Article in English | MEDLINE | ID: mdl-33610319

8.

Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.

Armstrong, Deborah K; Alvarez, Ronald D; Bakkum-Gamez, Jamie N; Barroilhet, Lisa; Behbakht, Kian; Berchuck, Andrew; Chen, Lee-May; Cristea, Mihaela; DeRosa, Maria; Eisenhauer, Eric L; Gershenson, David M; Gray, Heidi J; Grisham, Rachel; Hakam, Ardeshir; Jain, Angela; Karam, Amer; Konecny, Gottfried E; Leath, Charles A; Liu, Joyce; Mahdi, Haider; Martin, Lainie; Matei, Daniela; McHale, Michael; McLean, Karen; Miller, David S; O'Malley, David M; Percac-Lima, Sanja; Ratner, Elena; Remmenga, Steven W; Vargas, Roberto; Werner, Theresa L; Zsiros, Emese; Burns, Jennifer L; Engh, Anita M.

J Natl Compr Canc Netw ; 19(2): 191-226, 2021 02 02.

Article in English | MEDLINE | ID: mdl-33545690

9.

Rucaparib maintenance treatment for recurrent ovarian carcinoma: the effects of progression-free interval and prior therapies on efficacy and safety in the randomized phase III trial ARIEL3.

Clamp, Andrew R; Lorusso, Domenica; Oza, Amit M; Aghajanian, Carol; Oaknin, Ana; Dean, Andrew; Colombo, Nicoletta; Weberpals, Johanne I; Scambia, Giovanni; Leary, Alexandra; Holloway, Robert W; Amenedo Gancedo, Margarita; Fong, Peter C; Goh, Jeffrey C; O'Malley, David M; Armstrong, Deborah K; Banerjee, Susana; García-Donas, Jesus; Swisher, Elizabeth M; Cameron, Terri; Goble, Sandra; Coleman, Robert L; Ledermann, Jonathan A.

Int J Gynecol Cancer ; 31(7): 949-958, 2021 07.

Article in English | MEDLINE | ID: mdl-34103386

10.

Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial.

Ledermann, Jonathan A; Oza, Amit M; Lorusso, Domenica; Aghajanian, Carol; Oaknin, Ana; Dean, Andrew; Colombo, Nicoletta; Weberpals, Johanne I; Clamp, Andrew R; Scambia, Giovanni; Leary, Alexandra; Holloway, Robert W; Gancedo, Margarita Amenedo; Fong, Peter C; Goh, Jeffrey C; O'Malley, David M; Armstrong, Deborah K; Banerjee, Susana; García-Donas, Jesus; Swisher, Elizabeth M; Cameron, Terri; Maloney, Lara; Goble, Sandra; Coleman, Robert L.

Lancet Oncol ; 21(5): 710-722, 2020 05.

Article in English | MEDLINE | ID: mdl-32359490

11.

Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis.

Pothuri, Bhavana; Alvarez Secord, Angeles; Armstrong, Deborah K; Chan, John; Fader, Amanda N; Huh, Warner; Kesterson, Joshua; Liu, Joyce F; Moore, Kathleen; Westin, Shannon N; Naumann, R Wendel.

Gynecol Oncol ; 158(1): 16-24, 2020 07.

Article in English | MEDLINE | ID: mdl-32386911

12.

A phase I study of intravenous or intraperitoneal platinum based chemotherapy in combination with veliparib and bevacizumab in newly diagnosed ovarian, primary peritoneal and fallopian tube cancer.

Moore, Kathleen N; Miller, Austin; Bell-McGuinn, Katherine M; Schilder, Russell J; Walker, Joan L; O'Cearbhaill, Roisin E; Guntupalli, Saketh R; Armstrong, Deborah K; Hagemann, Andrea R; Gray, Heidi J; Duska, Linda R; Mathews, Cara A; Chen, Alice; O'Malley, David; Gordon, Sarah; Fracasso, Paula M; Aghajanian, Carol.

Gynecol Oncol ; 156(1): 13-22, 2020 01.

Article in English | MEDLINE | ID: mdl-31708167

13.

The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma.

Colombo, Nicoletta; Oza, Amit M; Lorusso, Domenica; Aghajanian, Carol; Oaknin, Ana; Dean, Andrew; Weberpals, Johanne I; Clamp, Andrew R; Scambia, Giovanni; Leary, Alexandra; Holloway, Robert W; Gancedo, Margarita Amenedo; Fong, Peter C; Goh, Jeffrey C; O'Malley, David M; Armstrong, Deborah K; Banerjee, Susana; García-Donas, Jesus; Swisher, Elizabeth M; Meunier, Juliette; Cameron, Terri; Maloney, Lara; Goble, Sandra; Bedel, Josh; Ledermann, Jonathan A; Coleman, Robert L.

Gynecol Oncol ; 159(1): 101-111, 2020 10.

Article in English | MEDLINE | ID: mdl-32861537

14.

The estrogen receptor-alpha S118P variant does not affect breast cancer incidence or response to endocrine therapies.

Button, Berry; Croessmann, Sarah; Chu, David; Rosen, D Marc; Zabransky, Daniel J; Dalton, W Brian; Cravero, Karen; Kyker-Snowman, Kelly; Waters, Ian; Karthikeyan, Swathi; Christenson, Eric S; Donaldson, Josh; Hunter, Tasha; Dennison, Lauren; Ramin, Cody; May, Betty; Roden, Richard; Petry, Dana; Armstrong, Deborah K; Visvanathan, Kala; Park, Ben Ho.

Breast Cancer Res Treat ; 174(2): 401-412, 2019 Apr.

Article in English | MEDLINE | ID: mdl-30560461

15.

Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients.

Fuh, Katherine C; Java, James J; Chan, John K; Kapp, Daniel S; Monk, Bradley J; Burger, Robert A; Young, Robert C; Alberts, David S; McGuire, William P; Markman, Maurie; Bell, Jeffrey; Ozols, Robert F; Armstrong, Deborah K; Aghajanian, Carol; Bookman, Michael A; Mannel, Robert S.

Gynecol Oncol ; 154(2): 420-425, 2019 08.

Article in English | MEDLINE | ID: mdl-31229298

16.

NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019.

Armstrong, Deborah K; Alvarez, Ronald D; Bakkum-Gamez, Jamie N; Barroilhet, Lisa; Behbakht, Kian; Berchuck, Andrew; Berek, Jonathan S; Chen, Lee-May; Cristea, Mihaela; DeRosa, Marie; ElNaggar, Adam C; Gershenson, David M; Gray, Heidi J; Hakam, Ardeshir; Jain, Angela; Johnston, Carolyn; Leath, Charles A; Liu, Joyce; Mahdi, Haider; Matei, Daniela; McHale, Michael; McLean, Karen; O'Malley, David M; Penson, Richard T; Percac-Lima, Sanja; Ratner, Elena; Remmenga, Steven W; Sabbatini, Paul; Werner, Theresa L; Zsiros, Emese; Burns, Jennifer L; Engh, Anita M.

J Natl Compr Canc Netw ; 17(8): 896-909, 2019 08 01.

Article in English | MEDLINE | ID: mdl-31390583

17.

Evaluation of osteopenia and osteoporosis in younger breast cancer survivors compared with cancer-free women: a prospective cohort study.

Ramin, Cody; May, Betty J; Roden, Richard B S; Orellana, Mikiaila M; Hogan, Brenna C; McCullough, Michelle S; Petry, Dana; Armstrong, Deborah K; Visvanathan, Kala.

Breast Cancer Res ; 20(1): 134, 2018 11 13.

Article in English | MEDLINE | ID: mdl-30424783

18.

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.

Coleman, Robert L; Oza, Amit M; Lorusso, Domenica; Aghajanian, Carol; Oaknin, Ana; Dean, Andrew; Colombo, Nicoletta; Weberpals, Johanne I; Clamp, Andrew; Scambia, Giovanni; Leary, Alexandra; Holloway, Robert W; Gancedo, Margarita Amenedo; Fong, Peter C; Goh, Jeffrey C; O'Malley, David M; Armstrong, Deborah K; Garcia-Donas, Jesus; Swisher, Elizabeth M; Floquet, Anne; Konecny, Gottfried E; McNeish, Iain A; Scott, Clare L; Cameron, Terri; Maloney, Lara; Isaacson, Jeff; Goble, Sandra; Grace, Caroline; Harding, Thomas C; Raponi, Mitch; Sun, James; Lin, Kevin K; Giordano, Heidi; Ledermann, Jonathan A.

Lancet ; 390(10106): 1949-1961, 2017 Oct 28.

Article in English | MEDLINE | ID: mdl-28916367

19.

AML and MDS associated with PARP inhibitor treatment of ovarian cancer.

Armstrong, Deborah K.

Gynecol Oncol ; 171: 162-163, 2023 04.

Article in English | MEDLINE | ID: mdl-36528399

20.

New Therapies for Ovarian Cancer.